James Schaller, MD, MAR a Lyme Literate doctor (LLMD) with 12 Textbooks on Lyme disease and coinfections
We need as many options to treat emerging infections like Bartonella as possible. While some of our experience since approximately 2002 has shown cures with advanced repeated microbiology and cytokine tracking. We want help to enhance treatment options. And to mention in our pending definitive Bartonella Textbook.
In this study mentioned below they “successfully identified various botanical [plant] extracts with activity 137 against stationary phase B. henselae, which has successfully been used as a model of persister 138 drug screens [53-56] because of its higher content of persister cells.”